Global genetic deletion of Hdac9 resulted in reduced weight gain, improved glucose tolerance and insulin sensitivity, and reduced ectopic lipid accumulation in high fat fed-mice, suggesting that HDAC9 plays a key role in obesity-related metabolic disease [11]. Here, INS is linked to metabolic disease.